{
  "title": "Eli Lilly CEO on Submitting COVID-19 Antibody Drug to FDA",
  "itunes:title": "Eli Lilly CEO on Submitting COVID-19 Antibody Drug to FDA",
  "description": "<p>Bloomberg Economics Senior U.S. Economist Yelena Shulyatyeva and Bloomberg Stocks Editor Dave Wilson discuss the latest FOMC minutes. Former Republican Strategist and Bloomberg Contributor Rick Davis provides a preview of the Vice Presidential debate. David Ricks, CEO at Eli Lilly, talks about submitting a COVID-19 antibody for FDA emergency approval. Bloomberg News Health Reporter Michelle Cortez shares a coronavirus and vaccine update. And we Drive to the Close with Rich Weiss, CIO of Multi-Asset Strategies at American Century Investments.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. </p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Bloomberg Economics Senior U.S. Economist Yelena Shulyatyeva and Bloomberg Stocks Editor Dave Wilson discuss the latest FOMC minutes. Former Republican Strategist and Bloomberg Contributor Rick Davis provides a preview of the Vice Presidential debate. David Ricks, CEO at Eli Lilly, talks about submitting a COVID-19 antibody for FDA emergency approval. Bloomberg News Health Reporter Michelle Cortez shares a coronavirus and vaccine update. And we Drive to the Close with Rich Weiss, CIO of Multi-Asset Strategies at American Century Investments.</p><p>Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway. </p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "67bf264e-08dd-11eb-9351-b3001359aa9f",
  "omny:clipId": "e983ef52-9a89-4003-a0ef-ae2b0057e2b0",
  "pubDate": "Wed, 07 Oct 2020 20:46:59 +0000",
  "itunes:duration": 2917,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/eli-lilly-ceo-on-submitting-covid-19-antibody-drug"
}